![]() |
|
|
SS Pan, T Iracki and NR Bachur
After anaerobic reductive activation by either NADPH cytochrome P-450 reductase (EC 1.6.2.4) or xanthine oxidase (EC 1.2.3.2), mitomycin C readily alkylated DNA. When the mitomycin C-alkylated DNA is digested by DNase, snake venom phosphodiasterase, and alkaline phosphatase, only partial release of the monofunctionally linked mitomycin C nucleotide adduct occurs. Cross-linked adducts are not released into dinucleotides but resist nuclease digestion and remain in oligonucleotides and insoluble precipitates. Kinetic analyses show that the nuclease- resistant fraction which is indicative of DNA cross-linking by mitomycin C takes place quite readily. This nuclease-resistant fraction is particularly significant when the amount of total bound mitomycin C is less than 15 mumol/mmol of DNA. The cross-linked mitomycin C product accounts for more than half of the total alkylation under all pH conditions tested. Our data suggest that particular DNA sites are available for DNA cross-linking by mitomycin C, and these sites are probably the preferred and immediate alkylating targets. Furthermore, DNA cross-links by mitomycin C are not the secondary product of monofunctional adducts. Activity of both flavoenzymes is pH dependent, hence, mitomycin C activation and the rate of DNA alkylation are pH dependent. At elevated mitomycin C alkylation of DNA, the highest amount of cross-linking occurs at neutral pH. High pressure liquid chromatographic separation of the nuclease-digested DNA detected one major and two less prominent mitomycin C adducts. These were verified to be mononucleotide mitosene types by UV spectra showing maximum absorbance at 312 and 250 nm. The major adduct was purified and identified as O6-(2'-deoxyguanosyl)-2,7-diaminomitosene by NMR, indicating that the O6 position of guanine is a preferred site in DNA for at least monofunctional linkage formation.
This article has been cited by other articles:
![]() |
W. Lang, J. Mao, T. W. Doyle, and B. Almassian Isolation and Identification of Urinary Metabolites of Porfiromycin in Dogs and Humans Drug Metab. Dispos., August 1, 2000; 28(8): 899 - 904. [Abstract] [Full Text] |
||||
![]() |
C. Nesti, F. Trippi, R. Scarpato, L. Migliore, and G. Turchi Cytokinesis-block micronucleus assay in primary human liver fibroblasts exposed to griseofulvin and mitomycin C Mutagenesis, March 1, 2000; 15(2): 143 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Tomasz, R Lipman, D Chowdary, J Pawlak, G. Verdine, and K Nakanishi Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA Science, March 6, 1987; 235(4793): 1204 - 1208. [Abstract] [PDF] |
||||